Special Issue "Viral Entry Inhibitors"
Deadline for manuscript submissions: closed (31 January 2013)
Virus entry into host cells is the earliest step in a productive infection process for both enveloped and non-enveloped viruses. The mechanism of virus entry of enveloped viruses has been studied quite extensively and two drugs targeted to the entry pathway of HIV-1 have been approved by the US FDA. Many more inhibitors are currently being studied to inhibit HIV-1 entry. However, the entry process of non-enveloped viruses is poorly understood. In this special issue, we hope to capture the recent developments in our understanding of the entry mechanism of both enveloped and non-enveloped viruses and their inhibition.
Dr. Asim Kumar Debnath
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed Open Access monthly journal published by MDPI.
- virus entry
- enveloped and non-enveloped viruses
- entry inhibitors
- fusion inhibitors
- mechanism of virus entry